IP Library Granted Patent US 9,550,802
Granted Patent B2
US 9,550,802 · App. 14/498,311 · Granted Jan 24, 2017

Anti-inflammatory macrolides

Inventors: Michael W. Burnet (Tübingen, DE); Christiane Bauerlein (Ofterdingen, DE); Mary Eggers (Ammerbuch, DE); Jan-Hinrich Guse (Tubingen-Buhl, DE)
C07H17/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,550,802
App. No.
14/498,311
Granted
Jan 24, 2017
Kind
B2
Abstract

The invention provides novel compounds and compositions and methods for making and using the compounds and compositions. In particular, the use of organic acid salts promotes solubility. These more soluble forms are suitable for use in various diseases, notably diseases of lung, muscle, metabolism and eyesight.

Claims (7)

1. A compound represented by the formula:

wherein

R 1 =P(═O)(OH) 2 , S(═O) 2 (OH), a saccharide or C(═O) -R 3 , wherein R 3 =(CH 2 ) 2 —C(═O)OH or an amino acid;

or a pharmaceutically acceptable salt or formaldehyde adduct thereof.

2. A salt of a compound of claim 1 containing an organic acid anion.

3. A salt of a compound of claim 1 containing acetic, formic, propionic, suberic, malic, citric, maleic, fumaric, succinic, azelaic, pyruvic, alpha ketoglutaric, aspartic, glutamic, sulfonic or ascorbic acids.

4. The compound of claim 1 or pharmaceutically acceptable salt thereof, wherein the compound is:

Continuity (4)
Continuation PCTUS2013034159 · Mar 27, 2013
Provisional Application 61635291 · Apr 18, 2012
Provisional Application 61616415 · Mar 27, 2012
Related Publication 20150232499A1 · Aug 20, 2015